Thromboembolic events in idiopathic inflammatory myopathy: a retrospective study in China.OBJECTIVE
 To investigate the clinical characteristics and risk factors for thromboembolic events in patients with idiopathic inflammatory myopathy (IIM).


 We retrospectively analyzed 1144 consecutive patients with IIM for arterial and venous thromboses and compared them with age- and sex-matched IIM patients without thrombosis.  Logistic regression analysis was used to analyze risk factors for thrombosis.


 Thromboembolic events occurred in 54.2% (13/24) of patients within 6 months before or after IIM diagnosis.  Thrombosis patients had a higher Cutaneous Dermatomyositis Disease Area and Severity Index score (p = 0.028), higher myositis disease activity assessment visual analogue scale score (MYOACT) (p < 0.001), and a greater proportion of them had varicose veins (p = 0.001), surgical history in the past 3 months (p = 0.039), malignancy (p = 0.018), and infection (p < 0.001).  The manual muscle test 8 score (p < 0.001) and albumin level (p = 0.003) were lower in thrombosis patients.  There was no significant difference between the two groups in glucocorticoid pulse therapy; however, intravenous immunoglobulin therapy was more commonly used in thrombosis patients (p = 0.04).  In multivariable regression models, malignancy, infection, longer duration of glucocorticoid treatment, and higher MYOACT were risk factors for thrombosis.  The cumulative survival time of IIM patients with thrombosis was significantly shorter than that of controls.


 CONCLUSIONS
 Malignancy, infection, longer duration of glucocorticoid use, and increased myositis disease activity are risk factors for thrombosis.  Patients with these risk factors should undergo screening for thrombosis.  Key Points • To investigate the clinical characteristics and risk factors for thromboembolism events in patients with IIM, we performed a retrospective study with IIM patients who experienced a thromboembolic event.  • We found that malignancy, infection, longer duration of glucocorticoid treatment, and a higher level of myositis disease activity were risk factors for thrombosis.  • The results suggest that patients with the above risk factors should undergo screening for thrombosis.
C